HomeCompareNPNYY vs JNJ

NPNYY vs JNJ: Dividend Comparison 2026

NPNYY yields 5.50% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPNYY wins by $10563.02M in total portfolio value
10 years
NPNYY
NPNYY
● Live price
5.50%
Share price
$7.46
Annual div
$0.41
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10563.05M
Annual income
$10,206,305,039.68
Full NPNYY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NPNYY vs JNJ

📍 NPNYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPNYYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPNYY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPNYY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPNYY
Annual income on $10K today (after 15% tax)
$467.16/yr
After 10yr DRIP, annual income (after tax)
$8,675,359,283.73/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, NPNYY beats the other by $8,675,355,297.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPNYY + JNJ for your $10,000?

NPNYY: 50%JNJ: 50%
100% JNJ50/50100% NPNYY
Portfolio after 10yr
$5281.54M
Annual income
$5,103,154,864.54/yr
Blended yield
96.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NPNYY
No analyst data
Altman Z
2.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPNYY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPNYYJNJ
Forward yield5.50%2.13%
Annual dividend / share$0.41$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$10563.05M$30.3K
Annual income after 10y$10,206,305,039.68$4,689.40
Total dividends collected$10538.19M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NPNYY vs JNJ ($10,000, DRIP)

YearNPNYY PortfolioNPNYY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,799$1,099.20$10,592$272.30+$1.2KNPNYY
2$15,049$2,424.23$11,289$357.73+$3.8KNPNYY
3$21,882$5,779.44$12,123$472.89+$9.8KNPNYY
4$39,121$15,707.46$13,141$629.86+$26.0KNPNYY
5$94,350$52,489.83$14,408$846.81+$79.9KNPNYY
6$337,572$236,617.67$16,021$1,151.60+$321.6KNPNYY
7$1,943,611$1,582,408.91$18,122$1,588.22+$1.93MNPNYY
8$19,109,398$17,029,734.74$20,930$2,228.20+$19.09MNPNYY
9$333,409,183$312,962,126.74$24,792$3,191.91+$333.38MNPNYY
10$10,563,052,866$10,206,305,039.68$30,274$4,689.40+$10563.02MNPNYY

NPNYY vs JNJ: Complete Analysis 2026

NPNYYStock

Nippon Yusen Kabushiki Kaisha provides marine, land, and air transportation services worldwide. The company offers various logistics services, including liner trading services, such as container shipping, and terminal and stevedoring services for containerships, car carriers, and cruise ships; and air cargo transportation services. It also provides bulk shipping services comprising transport services for finished automobiles, heavy construction machines, and used cars; transportation services for bulk freight, which include iron ore, coal, and wood chips; and transportation services for crude oil, petroleum products, chemicals, LNG, LPG, and ammonia for oil, petrochemical, and energy companies. In addition, the company is involved in the upstream areas of the supply chain for oil and natural gas. Further, it operates Asuka II, a luxury cruise ship; and manages commercial and residential buildings. Nippon Yusen Kabushiki Kaisha was incorporated in 1885 and is headquartered in Tokyo, Japan.

Full NPNYY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NPNYY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPNYY vs SCHDNPNYY vs JEPINPNYY vs ONPNYY vs KONPNYY vs MAINNPNYY vs ABBVNPNYY vs MRKNPNYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.